UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000026799 |
|---|---|
| Receipt number | R000030665 |
| Scientific Title | A randomized phse 3 study of carboplatin plus nab-paclitaxel with or without nintedanib for advanced non-small-cell lung cancer with idiopathic pulmonary fibrosis |
| Date of disclosure of the study information | 2017/04/01 |
| Last modified on | 2022/10/03 09:59:13 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/03/31 11:54:45 | ||
| 2 | Update | 2017/05/15 13:51:54 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2018/07/04 15:49:35 | Key inclusion criteria |
|
| 4 | Update | 2019/04/02 09:26:21 | Date of IRB Last follow-up date |
|
| 5 | Update | 2019/10/01 09:42:30 | Public title Public title Acronym Scientific Title Scientific Title Scientific Title:Acronym |
|
| 6 | Update | 2019/10/01 09:43:22 | Developmental phase |
|
| 7 | Update | 2019/10/01 09:43:49 | Target sample size |
|
| 8 | Update | 2020/04/01 09:08:11 | Recruitment status |
|
| 9 | Update | 2020/04/02 09:17:17 | Number of participants that the trial has enrolled |
|
| 10 | Update | 2022/10/03 09:55:21 | Recruitment status |
|
| 11 | Update | 2022/10/03 09:59:13 | Publication of results URL related to results and publications |
